Search

everythinglearnresearchcommunity

for

Search:↓

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Alopecia in captive rhesus macaques is affected by season, sex, age, housing, and stress, with complex links between stress hormones and hair loss.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Cognitive behavioral strategies help women with PCOS make lifestyle changes to improve their health.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.